The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / Redefining Private Practice in Laboratory Medicine
Professional Development Voices in the Community Profession Laboratory management Opinion and Personal Narratives Workforce Trends Regulation and standards

Redefining Private Practice in Laboratory Medicine

A reflection on the progress, pressures, and changing trends that might threaten the future of pathology

By Nishit Kumar Gupta 11/09/2026 Opinion 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: Redefining Private Practice in Laboratory Medicine

At a Glance

CategoryDetail
ConditionChallenges to sustainability in private laboratory medicine
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • New technologies require scientific validation, professional judgment, and accountable use.
  • High operating costs and price competition can challenge investment in qualified staff, reliable reporting, and quality assurance.
  • Workforce shortages, recruitment and retention difficulties, and concerns about remuneration and working conditions affect laboratory services.
  • Quality assurance must address the full testing process, from test request and specimen collection through reporting and clinical decision-making.
  • Digital systems and AI-assisted tools require attention to confidentiality, cybersecurity, validation, and human oversight.

Guideline-Based Recommendations

Diagnosis

  • The article does not provide disease-specific diagnostic criteria or recommendations.

Management

  • The article argues that adopting new technology requires scientific validation, professional judgment, and ownership of decisions.
  • It states that AI-assisted morphology, digital pathology, and automated decision support require appropriate validation and human oversight.
  • It proposes shared reference-testing facilities, pooled procurement, common training, collective quality-assurance programs, referral networks, and coordinated logistics as ways to support smaller laboratories.

Monitoring & Follow-up

  • The article states that laboratory quality should cover the testing process from test request through final clinical decision.
  • It states that expansion of diagnostic services should be accompanied by adequate supervision, competence, and accountability.

Risks

  • The article notes that errors may arise from pre-analytical through post-analytical stages, including poorly collected specimens and incorrectly communicated reports.
  • It raises concerns about confidentiality, cybersecurity, and data sharing in electronic reports, mobile applications, cloud systems, and interconnected health records.
  • The article states that reagent-purchase commitments can create long-term commercial dependence.
  • The article identifies workforce shortages, rising operating costs, and price competition as pressures on sustainable laboratory services.

Patient & Prescribing Data

Patients whose diagnostic testing is provided by private and local laboratories.

The article does not discuss prescribing or treatment. It emphasizes accurate testing, responsible handling of patient information, and continuity of diagnostic services.

Clinical Best Practices

  • The article emphasizes professional accountability for diagnostic accuracy and quality across the testing process.
  • It states that degrees or diplomas cannot substitute for hands-on training, technical competence, and understanding of laboratory quality.
  • It argues that emergency coverage and service continuity require better staffing, fair compensation, and sensible work arrangements.
  • The article emphasizes responsible handling of patient information and notes the relevance of data-protection frameworks, including India’s Digital Personal Data Protection Act 2023.
  • It calls for regulation to be transparent, proportionate, and uniformly implemented while maintaining quality and patient safety.

Related Resources & Content

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Nishit Kumar Gupta

Nishit Kumar Gupta, MD is Director, Nishit Clinical Laboratory, Paschim Vihar, New Delhi, India.

More Articles by Nishit Kumar Gupta

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.